News

The grant will be used by America Stem Cell and Wake Forest Institute of Regenerative Medicine (WFIRM) scientists to explore the combination of ASC-101 and amniotic fluid-derived stem

By using fresh undiluted whole blood from a large cohort of donors, the ProStorm assay provides a sensitive evaluation of cytokine responses to a therapeutic in one simple

The Software-as-a-Service (SaaS) application offers flexible toolset that allows sponsor and clinical research organization staff to quickly and easily build and manage their own studies. iMedNet EDC includes

The histone reagents are expected to work as tool for researchers seeking to prosecute key drug targets in the field of epigenetics. The modified histone reagent provision will

The evaluation of the safety of JX594 followed by sorafenib in patients with advanced HCC was the primary objective of the study while secondary endpoints included the effect

Under the agreement, EMD Millipore will provide its STEMCCA reprogramming kits for use of iPS cells in research applications. iPS cells, which are discovered by Shinya Yamanaka of

The primary outcome measure, change from baseline on the inattention subscale of the Conners’ Adult ADHD Rating Scale-Investigator-Rated (CAARS-INV), after four weeks of treatment versus placebo was not

The additional indication is for the active immunisation against pneumonia caused by Streptococcus pneumoniae in infants and children from six weeks up to five years of age. The

Lifeline CEO Jim Holmes said the System patent completes Lifeline’s three software patents. ”We now have our Methods, Device and System patents which provide the Company with protection